Screener
Ligand Pharmaceuticals LGND Total Cost of Revenue
Discontinued — last reported Q3 '19
Total Cost of Revenue at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The source filing: Ligand Pharmaceuticals’s 10-Q, filed November 8, 2019. Open the filing →
- Filed
- Nov 8, 2019
- Fiscal quarter
- Q3 FY2019
- Calendar quarter
- Q3 2019
- Accession
- 0000886163-19-000199
FAQ
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.